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1 INTRODUCTION 
1.1 Why Environmental Pollutants Should Be Investigated 
Environmental pollutants can have a big impact on human health, because humans are exposed to 
them in their everyday life without having a big choice to avoid exposure. They are virtually 
everywhere: in the air, on plants and in animals that are consumed (1), (2). Several diseases, including 
reproductive and developmental issues, neurodegeneration and cancer, are results of continuous 
exposure to toxicants in our environment (1), (3)- (5). Even some idiopathic illnesses might have their origin 
in chronic exposure to low-dose environmental contaminants (6), (7). But still, not enough awareness has 
been addressed to this problem, as only few studies have been performed on chronic and low-dose 
exposure. Lacking prove of these effects results in continued ignorance of possible health risks and on-
going leakage of environmental pollutants into the environment. But this happened not only in past 
years, even nowadays, disposal of contaminated waste or use of not yet banned pesticides increases 
environmental toxicant burden. Although measurements were taken since the 1970s to reduce 
methylmercury (MeHg) emissions, they are still reaching critical levels, especially in Asia (8). Legally 
compulsory regulations for persistent organic pollutants (POPs) on a word-wide level were not 
achieved earlier than in 2004, when the Stockholm Convention, a treaty formulated by the United 
Nations Environment Program (UNEP) to reduce and limit the use and disposal of persistent organic 
pollutants (POPs), entered into force (9). Both, MeHg and POPs, share some common properties, 
including long half-life, lipophilicity, volatility and toxicity (1), (10), but only POPs are regulated on a world-
wide basis. Global cycling of MeHg, illustrated below (figure 1), shows quite plainly why world-wide 
legally binding regulations, like the Stockholm Convention for POPs, would be useful for MeHg too. 
  
Mercury vapour from either anthropogenic or natural origins, described below, will be retained in the 
atmosphere for approximately 1 year which in turn leads to a global distribution of mercury. This 
atmospheric mercury will be transformed to mercuric mercury (Hg2+) by oxidation. Next, Hg2+ gets 
deposited back on the earth crust by rain and enters aquatic systems in which mercury from factories 
is leaked too. By evaporation of the volatile mercury vapour back into the atmosphere, the cycle is 
completed, as can be seen in figure 1(1).  
In aquatic sediments Hg2+ gets methylated mostly by sulphate-reducing bacteria which is thought to 
have a protective effect on the bacteria, as for them inorganic mercury is more toxic (11). By 
consumption of these methylating bacteria by aquatic organisms, MeHg enters the food chain and 
accumulates in organisms. Finally, those fish will be consumed by humans and thus enter the human 
body (1). 
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FIG. 1. Schematic drawing of the environment polluting vicious circle of MeHg. Mercury enters into the 
environment by various natural or anthropogenic sources, gets methylated by aquatic microorganisms which are 
consumed and accumulated in marine predators. By consuming sea food with high accumulated MeHg burden, 
MeHg enters the human body. Figure from Clarkson and Magos (2006) (1). 
 
 
This demonstrates that mercury gets distributed throughout the whole world by displacement in the 
atmosphere or in oceans and is not limited to the surroundings of the MeHg emitting source. The 
world-wide cycling and harmful health effects are already known for POPs which lead to adopting the 
Stockholm Convention. But still many people are unaware of the health effects of low-dose (< 1 µM) 
MeHg exposure, and the fact that MeHg in combination with POPs might even increase the toxicity of 
MeHg. That’s why it is necessary to investigate and highlight all harmful aspects and possible 
interactions with POPs to show up the urgency for a worldwide regulatory treaty of MeHg too. 
 
1.2 Methylmercury (MeHg) 
1.2.1 Sources of Mercury and MeHg 
Due to various transformation processes MeHg can be generated from every form of mercury. Thus, 
all mercury sources contribute to the global MeHg burden (1). According to the United Nations 
Environment Programme’s Global Mercury Assessment 2013 (2) 10% of the current mercury emission 
and re-emission into the atmosphere are due to natural sources, whereas 30% have anthropogenic 
origin. The final 60% are due to re-emission of previously deposited mercury. Natural sources that emit 
mercury into air and water include weathering of rocks that contain mercury (e.g. cinnabar), erupting 
volcanoes or geothermal activities. The anthropogenic source comprises a broad variety of sources 
such as mining, small-scale gold-mining, burning of coal and fossil fuels, metal recycling, chlor-alkali 
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industry to manufacture chlorine and caustic soda, production of vinyl-chloride monomers, cement 
production, oil refining and dental amalgam (2). 
Also several products, listed in table 1, people were or are exposed to in their daily life, contain organic 
or inorganic mercury. Thus, they also contribute to a higher MeHg burden, not only in the environment, 
but through direct exposure in human bodies too.   
 
TABLE 1: Physical and chemical appearances of mercury; routes of exposure to humans in past and present-
day. Present-day exposure is marked as *. Table from Clarkson and Magos (2006) (1). 
  
Inorganic mercury 
Hg vapour Mercurous Mercuric 
Hg° Hg-Hg2,+ 
 
Hg2,+ 
Occupational* Laxatives Skin creams* 
Dental amalgam* Teething powder  
 
Organic mercury 
Short chain alkyl Other organics 
CH3(CH2)n-Hg+ 
 
(R-C-Hg+) 
MeHg in fish* Phenyl Hg as antiseptics 
Ethyl mercury in preservatives*  
 
Focussing on MeHg, especially consumption of fish living in saltwater that reach a high age and thus 
accumulate high MeHg concentrations contribute to increased MeHg levels in human bodies. So do 
mushrooms if they are grown in a ground with high MeHg burden. Interestingly, plants do not tend to 
accumulate MeHg even if their soils are contaminated with MeHg (12).  
 
1.2.2 Adverse Health Effects of MeHg 
The most common route of MeHg absorption is by ingestion. In that case the intestinal absorption rate 
is nearly 100% (13), (14). Once entered the bloodstream, MeHg will be taken to every part of the body, 
including the brain. MeHg and can even cross the placenta and thus enter into the body of the foetus 
(1) who suffers from undefined and widespread brain damage due to prenatal MeHg exposure (15). 
The ability of MeHg to cross the blood-brain-barrier is especially harmful, as the brain is the most 
susceptible organ and thus, is the mainly affected area by MeHg. Several cortical brain structures are 
harmed by MeHg toxicity, such as the visual centre of the occipital lobe or the primary auditory area 
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of the temporal lobe. Furthermore, there are MeHg-induced cortical lesions, resulting in olfactory and 
gustatory disturbances (16). 
Additionally, brain cells are not equally susceptible to MeHg: MeHg is especially harmful for neurons. 
Astrocytes were found to be less susceptive than neurons, whereas all other non-neuronal cells were 
shown to be the most resistant (17).  
 
1.2.3 MeHg Poisonings 
Two big MeHg poisonings occurred in Japan and Iraq in the past century. The symptoms of affected 
people strongly point out what has been described in the paragraph above: The central nervous system 
is the most susceptible organ to MeHg. 
Ekino et al. (2007) (16) reported in their paper about the first big epidemic MeHg poisoning that 
occurred in Japan at the beginning of the 1950s. An acetaldehyde plant was leaking MeHg chloride into 
the Minamata bay. People in this area have a very high fish consumption and thus were exposed to 
high MeHg concentrations over a decade of years, causing severe acute mercury poisonings, referred 
to as Minamata disease. Minamate disease shows symptoms such as paresthesia around the lips, 
seeing and hearing impairment, olfactory and gustatory disturbances, ataxic gait, dysarthria as well as 
somatosensory and psychiatric disorders and even death. Prenatally exposed children suffered from 
damage of the cerebral cortex as well, which resulted in disturbances in mental and motor 
development. After changing the drainage from the bay to a river which was flowing into the sea, 
MeHg was more diluted and widely distributed. Thus, people were exposed to a lower dose of MeHg 
but over a period of 20 years, resulting in the chronic Minamata disease which is characterised by 
starting with paraesthesia of the limbs and around the lips, steadily leading to more severe symptoms 
as described in the acute disease (16).  
The second epidemic poisoning occurred in Iraq in the winter of 1971-1972 when people prepared 
bread from wheat grains treated with a MeHg fungicide. They exhibited the same symptoms as people 
affected by Minamata disease (18).  
 
1.3 Persistent Organic Pollutants (POPs) and Organochlorines 
Besides MeHg, another group of environmental pollutants was investigated: POPs. POPs refer to 
organic compounds which remain in the surroundings and persist in living beings, with extensive half-
lives in ecological systems and biota. Those mostly lipophilic compounds, which concentrate in adipose 
tissue, gradually accumulate in the bodies of predator animals along the food chain and exhibit toxic 
effects in living organisms (10). 
POPs are volatile compounds at ambient temperature and thus can travel long distances before 
deposition on the earth crust, which means that they can reach even remote areas all around the world 
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(10). POPs belong to one of the most hazardous and harmful compounds discharged in the surroundings. 
Aware of this fact, there has been made much effort to eliminate, restrict and prevent unintentional 
production or use of the most detrimental environmental pollutants. They are referred to as the Dirty 
Dozen and listed in table 2 (19). Since 2001 they are regulated on a legally-binding basis by adopting the 
Stockholm Convention. Ten years later another 10 compounds, including β-hexachlorocyclohexane, 
were added to the initial ones (20). 
 
TABLE 2: List of the first 12 regulated compounds, known as Dirty Dozen. Table from chm.pops.int (19).  
Pesticides Industrial chemicals By-products 
Aldrin* Hexachlorobenzene (HCB)*# Hexachlorobenzene (HCB)*# 
Chlordane* Polychlorinated biphenyls 
(PCB)*# 
Polychlorinated biphenyls 
(PCB)*# 
DDT+  Polychlorinated dibenzo-p-
dioxins (PCDD)# 
Dieldrin*  Polychlorinated dibenzofurans 
(PCDF)# 
Endrin*   
Heptachlor   
Hexachlorobenzen  
(HCB)* 
  
Mirex*   
Toxaphene*   
* Elimination, * Restriction, # Reduce and ultimately eliminate unintentional production 
 
Organochlorines are a subgroup of POPs that comprise aliphatic and aromatic compounds with at least 
one chlorine substitute. This chlorine substitute contributes to the organochlorines’ lipophilic 
character, increasing their uptake and storage in fatty tissue (21). Furthermore, it facilitates the crossing 
of the blood-brain-barrier and placenta (22).  
The carbon-chlorine bond exhibits big stability towards degradation due to the resistance against 
hydrolysis. Increasing stability comes along with increasing chlorination. The structures of the organic 
compounds play also an important role in the organochlorines’ susceptibility towards biodegradation: 
aromatic rings exhibit greater stability than aliphatic structures do. Biotransformation of 
organochlorine pollutants (OCPs) is essential to reduce amounts of POPs in the environment and the 
body, as biotransformed, and hence hydrophilic forms, are secreted more easily and quickly from the 
body (23).  
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The aforementioned structure is illustrated in figure 2, where all used organochlorine compounds are 
shown with the structural formula. They will be briefly described in the sections below.   
 
Chemical Structures of the Used Organochlorine Compounds 
 
                                                              
                     4,4’-DDE                                                                                                      Dieldrin           
                       
                                                                                          
                          HCB                                                                                                             β-HCH               
        
                                                                      
                         δ-HCH                                                                                                          PCB-138  
 
 
PCB-153 
FIG. 2. The above described POPs depicted with their chemical structure. 
 
1.3.1 4,4´-DDE   
4,4´-DDE is a metabolite of the insecticide 4,4´-DDT. The metabolite 4,4’-DDE possesses no insecticide 
properties and is excreted more slowly than DDT (4).  
DDT, is maybe the most prominent organochlorine and has a long history of applications. It was used 
from the 1940s on in agriculture (e.g. the Colorado potato beetle plague in Europe in 1941), as anti-
lice product (typhus epidemy in Naples 1943) and for combatting malaria. After health concerns on 
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DDT, it finally got banned in most developing countries in the 1970s (24). Nowadays, DDT is listed in the 
Stockholm Convention which states that the use of DDT is now restricted to indoor residual spraying 
only and with the sole purpose of combating malaria, if there are locally no other appropriate 
pesticides available (25). 
DDT belongs to the group of endocrine disruptors that due to their oestrogenic and anti-androgenic 
effects by mimicking oestrogen can lead, amongst others, to cancer (26). According to the International 
Agency for Research on Cancer (IARC), DDT exhibits possible carcinogenicity in humans (27). Further 
adverse health effects include reproductive toxicity, reduced fertility, miscarriages and neonatal 
deaths as well as congenital defects (26). DDT also accounts for neurodevelopmental delays at prenatal 
exposure (28). 
 
1.3.2 Dieldrin 
Dieldrin describes an insecticide with the main compound called HEOD (1,2,3,4,10,10-hexachloro-6, 7-
epoxy-l,4,4a,5,6, 7 ,8,8a-octahydro-endn-1 , 4-exo- 5, 8-dimethanonapthalene) and additional 
insecticidal compounds. It has bioaccumulative properties as it exhibits hydrophobic properties and a 
long half-live in the environment. Dieldrin is a metabolite of the pesticide aldrin which is 
biotransformed in plants or animals (29).  
Dieldrin was used as insecticide against soil insects, such as termites, but was also used against moths 
in the textile industry (30).  Nowadays, it is banned, as regulated in the Stockholm Convention (25). 
Dieldrin forms also part of the group of endocrine disruptors due to their interaction with the 
oestrogen receptor, which in turn leads to its big impact in breast cancer development (31). 
Furthermore, there is evidence for an anti-androgenic effect of dieldrin, harming the male 
reproductivity system due to developmental anomalies which include the central nervous system too 
(32). Acute neurotoxic effects include nausea, headache and convulsions (29). 
 
1.3.3 Hexachlorbenzene (HCB) 
Hexachlorbenzene’s structure resembles benzene, which is an aromatic hydrocarbon. Its hydrogen 
atoms are substituted by chloride atoms resulting in the chemical formula C6Cl6. Due to its lipophilic 
properties it is highly bioaccumulative (33).  
In history, HCB served many purposes not only in agriculture but also in industry. In agriculture it was 
used as fungicidal seed dressing for barley, oats, rye and wheat until the 1970s when awareness was 
addressed to possible harmful effects of HCB on the ambient and public health. Although in some 
countries its use continues, for above-mentioned purposes and additionally as anti-scabies pesticide 
in Tunisian sheep (34). HCB occurred also in industry, in manufacturing pyrotechnics, pesticides and was 
used for preserving wood (35). It is also present as by-product in producing chlorinated solvents (36) as 
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well as in chlor-alkali factories (33). Furthermore, municipal incinerations are contributing to the 
elevated HCB levels in the ambient (35).  
Adverse health effects include, porphyria cutanea tarda (33) (a disease affecting the synthesis of heme) 
and possible carcinogenicity in humans (37). In high-doses and short-term exposure HCB accounts for 
symptoms such as bloated thyroid glands, scarring and infantile arthritis in offspring of exposed 
mothers. In experimental studies animals showed symptoms of neurotoxicity including tremors, 
paralysis, weakness and convulsions (33). Furthermore, exposure to HCB can have harmful effects on 
the neurodevelopment of the unborn (38). 
         
1.3.4 Hexachlorocyclohexane (HCH) 
Hexachlorocyclohexane (HCH), previously called benzene hexachloride (BHC), occurs in eight isomeric 
forms. The most important ones, regarding environmental pollution, are alpha (α)-, beta (β)-, gamma 
(γ)-, delta (δ)-and epsilon (ε)-hexachlorocyclohexanes, as they are the most abundant ones in the 
environment. The now-banned technical-grade HCH, was used as pesticide and comprises all 
aforementioned isomers, although nearly all the insecticidal effects are due to the γ-isomer (3).  
Due to non-regulated dumping of HCH waste for several years all over the world, there is still a big 
amount of those isomers leaking into the ambient. The more persistent forms of the above mentioned 
isomers include β- and δ-HCH (39). 
Several adverse health effects are reported for HCH: All forms of HCH exhibit kidney and liver toxicity 
and possible endocrine disruptive effects and there is evidence showing that β-HCH has human 
carcinogenic effects, thus evoking liver cancer in animal studies. Furthermore, it can produce 
immunosuppression. β-HCH also accounts for neurological deficits such as behavioural changes, 
reduced nerve conduction velocity, seizures and even coma  (3). Prenatal exposure can lead to 
teratogenic, genotoxic and mutagenic effects (39). 
 
1.3.5 Polychlorinated Biphenyls (PCBs) 
There are 209 congeners of polychlorinated biphenyls (PCBs) and usually are sold as mixtures of these 
congeners (e.g. “Aroclor”). They differ from each other in their degree of chlorination on their biphenyl 
(= two linked benzenes) structure. With increasing degree of chlorination PCBs become more 
persistent in sediments and soil. Their lipophilic properties make them bioaccumulate in organisms, 
resulting in food consumption, especially fish, as major contribution to the body burden in humans.  (5) 
The congeners to be most quantitatively and commonly detected in humans are the numbers 138, 
153, and 180 (40). 
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Due to their low inflammable and well insulating properties they were used as coolants and lubricants 
in electrical devices. Furthermore, they were heavily used in a wide range of applications, such as flame 
retardants, paints, inks, metal coatings, and wire insulators (5).  
Toxic effects of PCBs show a broad range of symptoms affecting skin, thyroid, liver as well as the 
immune system. Furthermore, they cause neurodevelopmental abnormalities, which are probably due 
to the endocrine disrupting properties of PCBs that also affect reproductivity and can induce cancer, 
primarily breast and liver cancers. As the brain and the former mentioned systems are not yet fully 
developed in children and foetuses, the harmful effects of PCBs will have more profound consequences 
if human beings are exposed pre- or neonatally to them, thus rendering children and unborn more 
vulnerable to PCBs  (5). 
 
1.4 Molecular Mechanisms of MeHg and POPs Neurotoxicity 
1.4.1 The Mitochondrial System 
Mitochondria play an essential role in cell physiology as this is the place where oxidative metabolism 
occurs that generates adenosine triphosphate (ATP), which is crucial for providing energy to the cell. 
MeHg can have harmful effects on mitochondria by inhibiting the electron transport chain and thus 
increasing ROS (41), as illustrated in figure 3 and 4. Inhibiting or depressing effects of the respiratory 
chain were also demonstrated for dieldrin (42) and PCBs (43). Literature for HCB, HCH isomers and DDE 
is limited on this topic.  
 
1.4.2 Calcium (Ca2+) Dyshomeostasis and Glutamate-Induced Excitotoxicity  
Ca2+ is an important cell-signalling molecule with the ability to induce cell death pathways (41). It can 
also cause mitochondrial membrane potential (ΔΨm) loss by stimulating the opening of the 
mitochondrial transition pore (MTP), a pore by which molecules up to 1 500 Da can cross the 
impermeable inner mitochondrial membrane (44). Both, intracellularly released Ca2+ of mitochondria 
and extracellular influx of Ca2+, contribute to the induction of aforementioned target effects of Ca2+ 
signalling. It is known that MeHg has the ability to increase the intracellular calcium concentration 
[Ca2+]i (41), amongst other mechanisms, also by releasing intramitochondrial Ca2+, thus contributing to 
mitochondrial membrane discharge (45), (46).  
Several organochlorines have been investigated regarding their impact on [Ca2+]i levels: Dieldrin does 
not contribute to [Ca2+]i increase (47), whereas β-HCH and PCBs increase [Ca2+]i (48), (49). The rise in [Ca2+]i 
caused by PCBs is due to an increased influx of extracellular Ca2+ (49), whereas the mechanism of 
increased [Ca2+]i  by β-HCH is not known yet. 
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MeHg can increase [Ca2+]i not only by intramitochondrial Ca2+ release, but by MeHg-induced 
excitotoxicity too. MeHg increases extracellular glutamate levels, which lead to increased intracellular 
Ca2+ levels (41). This process is shown in figure 3.  
 
FIG.3. i&ii. MeHg exposure leads to an increase in extracellular glutamate levels which is most likely due to a 
MeHg-induced inhibitory effect on glutamate reuptake of astrocytes. iii. This increased extracellular glutamate 
concentration causes an N-methyl D-aspartate (NMDA)-type glutamate receptor hyperactivation that results in 
a rise in Ca2+ conductance into the intracellular space where iv. Ca2+ induces cell death pathways v. or harms 
mitochondria which raises reactive oxygen species production.(i-iv) (50) vi. Ca2+ release and increased oxidative 
stress is also caused by MeHg acting directly on mitochondria. vii. Free radicals in turn lower the levels of 
glutamate taken up by astrocytes thus again increasing oxidative stress (51). Figure from Farina et al. (2011) (41). 
   
1.4.3 The Glutathione System 
Glutathione (γ-glutamyl-cysteinyl-glycine) is an enzyme which is crucial to protect against oxidative 
stress and is abundant in nearly every cell. Glutathione is also abbreviated as GSH, as the thiol group 
(-SH), the active site of the enzyme, is important in catalysing reactions. GSH is especially susceptible 
to MeHg as it has a high affinity for thiol groups. Due to its reducing capabilities, GSH is responsible for 
protecting the reduced form of important cysteine residues in proteins and enzymes. GSH is also in 
charge of neutralizing peroxides and thus inhibiting free radicals and oxidative stress, by using 
glutathione peroxidase which catalyses the following reaction: 
H2O2 + 2GSH → GS-SG + 2H2O 
In the following step, NADPH reduces the oxidized state of GSH (GS-SG) via the action of glutathione 
reductase to obtain reduced GSH again: 
GS-SG + NADPH + H+ → 2GSH + NADP+ (52) 
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MeHg interferes with the GSH system on several levels: Figure 4 illustrates the interactions of MeHg 
with the GSH system, including binding of MeHg to the thiol groups of GSH due to the high affinity of 
MeHg for thiols. Furthermore, it involves reduced GSH reductase activity and reduced GSH peroxidase 
activity (53). 
There is also evidence for effects of some organochlorines on the GSH system. It was demonstrated 
that PCBs influence GSH reductase and peroxidase, but are not changing GSH levels (54). Nor does 4,4´-
DDE affect GSH levels (55), whereas for β-HCH and HCB no relevant literature was available. 
 
 
FIG. 4. i. MeHg is inhibiting the tricaboxylic acid cycle which leads to electron transport chain inhibition. This 
interference with the respiratory chain is responsible for increased levels of reactive oxygen species including 
hydrogen peroxide (H2O2) and superoxide anions (O2-·). Furthermore, the inhibition leads to a discharge of the 
proton gradient across the mitochondrial inner membrane and subsequently decreases ATP production. (56) ii. 
Due to its high affinity for thiols, MeHg binds to the thiol group of glutathione (GSH) which hampers the enzyme’s 
reducing abilities. Furthermore, it leads to a depletion of GSH levels because the MeHg-GSH complex is excreted 
as detoxifying mechanism, which in turn increases reactive oxygen levels. (41) iii. GSH peroxidase (GPx) activity is 
reduced by MeHg exposure. iv. Prenatal exposure to MeHg can also lead to reduced GSH reductase (GR) activity. 
(iii and iv)(57) Figure from Farina et al. (2011) (41). 
 
1.4.4 Effects of MeHg and POPs on Microtubules 
Playing an important role in cellular morphology and stability, consequences of microtubules affected 
by MeHg and organochlorines can be fatal. Microtubules are polymers of α- and β-tubulin protein 
dimers with each dimer containing 15 thiol groups (58). Binding of MeHg to the thiols of the dimers leads 
to depolymerisation of the microtubules (59). This depolymerisation causes a microtubule disassembly 
that results in neuronal degeneration. Literature on organochlorines affecting microtubules was found 
for PCBs only: PCBs cause a disruption of the actin cytoskeleton (60) which in turn can affect 
microtubules involved in branching of the axons (61). This will result in a less dense neurite network. 
Interestingly, the disruption of the actin cytoskeleton could be observed before cytotoxicity was 
detectable (60).  
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1.5 The Involvement of MeHg and POPs in Neurodegenerative Diseases 
The range of diseases caused by organochlorine compounds and MeHg intoxication comprises a big 
variety of symptoms. MeHg is known for its acute and chronic, devastating effects on the human brain 
and symptoms associated with this brain damage (1). But its link to neurodegenerative illnesses is not 
very clearly established yet, which applies for OCPs too. But there is evidence that several 
environmental pollutants, organochlorines and MeHg included, are risk factors for neurodegenerative 
diseases, such as amyotrophic lateral sclerosis (6), Alzheimer’s disease (62), (63) and Parkinson’s disease 
(PD) (62), (64), (7) .  With an increasing number of people suffering from neurodegenerative diseases (65), it 
is important to investigate potential risk factors of these illnesses, as their origin still remains unclear. 
The reason for the still lacking explanation of the aetiology of several neurodegenerative diseases 
might be due to the fact that a variety of complex mechanisms, including neurotransmitter systems, 
are involved in the development of these diseases.  
We chose to investigate the influence of environmental pollutants with regard to PD, as cortical 
atrophy is present in PD patients (66) and thus is related to our studies of environmental toxicant 
neurotoxicity in cortical neurons. Although cortical atrophy can be found in Alzheimer’s disease (AD) 
too (62) and AD ranges first as most common neurodegenerative disease, PD is the second most 
common (67) but with an earlier onset. The age of PD onset in patients is around 60 years with early-
onset PD beginning already at the age of teenagers, compared to an average age of onset of 73 years 
in AD, with the youngest patients ranging around 50 years (68). That means that PD is more likely to 
affect working people which will lead to a high economic burden, due to loss of work force and 
intensive costs for care. Therefore, we decided to investigate the effect of MeHg and organochlorines 
in combination with two neurotransmitters involved in PD pathology: acetylcholine (ACh) and 
dopamine (DA) (69). 
 
1.6 Parkinson’s Disease (PD) 
With about 1% of the world´s population over 60 suffering from PD, it is one of the most frequent 
movement disorders worldwide. It is a neurodegenerative illness characterised by loss of dopaminergic 
neurons mainly in the substantia nigra and, according to recent findings, cholinergic neurons mainly in 
the nucleus basalis of Meynert (70), (71). Symptoms of PD include akinesia (incapacity of movement) 
respectively bradykinesia (slower movements), tremor, rigor (muscle stiffness due to coactivation of 
agonist and antagonist muscles) and a postural disorder. Additional symptoms may be present 
including pain, depression, cognitive impairment and in severe cases dementia (72). Currently, no cure 
for PD is available. Only symptoms can be eased by medication, which is described in more detail 
below. But there are studies going on that are investigating transplantation of stem or progenitor cells 
into various parts of the brain, including the striatum (73) and the cortex (74), to improve symptoms 
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caused by neuronal cell loss. Although the aetiology of PD is not known yet, there are some risk factors 
associated with PD: increasing probability with age, genetic predisposition as well as exposure to 
environmental pollutants (70). On molecular level, several mechanisms were suggested being involved 
in neurodegeneration of dopaminergic and cholinergic neurons such as oxidative stress, excitotoxicity, 
mitochondrial dysfunction, inflammation and apoptosis (75).  
 
1.7 The Involvement of Dopamine (DA), Acetylcholine (ACh), MeHg and POPs in PD  
It has been suggested that the underlying mechanisms of PD involve a DA-ACh imbalance, which has 
been proposed, as medication regulating the ACh and DA balance improved symptoms of PD. Before 
L-DOPA (L-3,4-Dihydroxyphenylalanin) was available, PD was treated with anticholinergic drugs to 
improve motor symptoms (76), although the mode of action of anticholinergic drugs is not fully 
understood yet. Nowadays, only young patients are given anticholinergics, if they only suffer from 
tremor and no difficulties with gait. Usually PD is treated with L-DOPA in more severe cases but as 
motor fluctuations can develop in long-term use, young people with mild symptoms are preferentially 
treated with anticholinergic drugs first. But anticholinergics exhibit side effects too, especially in older 
patients where they can lead to cognitive impairment (77). L-DOPA is used as the most powerful anti-
PD medication. As DA cannot cross the blood-brain-barrier (BBB) via the large neutral amino acid 
transporter, the BBB-crossable L-DOPA is given that readily enters the brain. Inside the brain it is 
decarboxylized to DA by DOPA-decarboxylase. Thus, L-DOPA substitutes for the DA of the lost 
dopaminergic neurons. Also DA agonists can be used in PD treatment because they exhibit less side 
effects although their effect is not as strong as the one from Levodopa (72). Concluding, medication that 
regulates ACh and DA levels provides evidence that cholinergic and dopaminergic systems are mainly 
affected. Further evidence for an ACh-DA imbalance is provided by a recent study by Ziegler et al. 
(2013) (78). They demonstrated that the loss of dopaminergic neurons in substantia nigra occurs before 
cholinergic cells die in the basal forebrain. That means that there is a time span, where cholinergic 
neurons are still active whereas dopaminergic activity is already reduced.  Thus leading to a DA-ACh 
imbalance and explaining, why anticholinergic drugs improve tremor in early PD stages but worsen 
cognitive symptoms in old PD patients with advanced cholinergic cell loss.  
 
But not only a disturbed DA-ACh balance is associated with PD. As mentioned above, there is also a 
possible link between organochlorine insecticides, MeHg and PD (62), (64), (7). A study by Richardson et al. 
(2011) (79) found an association between increased serum β-HCH levels and increased PD risk. 
Researchers in Greenland found higher DDE levels in PD patients than in the control (80).  This literature 
findings are in agreement with another study which demonstrates that higher incidence of PD is 
associated with occupational exposure to organochlorines (81). Additionally, mercury body burden is 
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also linked to PD (64), (7). Furthermore, MeHg and organochlorines are known to induce harmful effects, 
including cell death, oxidative stress or mitochondrial depolarization (see section 1.4) which may 
contribute to neuronal loss in PD too. 
The various interaction of MeHg with ACh (see section 1.8) and DA (see section 1.9) might as well 
influence the development or severity of symptoms in PD.  
 
1.8 ACh and its Importance in the Central Nervous System 
Cholinerigc neurons synthesize ACh, an ester of acetic acid and choline, which plays an important role 
in sensory input regulation (82), attention (83) as well as cortical neuromodulatory effects (84). Incorrect 
neuromodulation by ACh can cause mental disorders ranging from schizophrenia to depression (85) and 
is present in neurodegenerative diseases, including AD (86) and PD (69).  
 
 ACh-containing neurons occur in three cholinergic modulation systems: There are cholinergic neuron 
groups in the media septal nuclei and the nucleus basalis in the basal forebrain projecting to cortex 
and hippocampus. The third one is the pontomesencephalotegmental complex from where neurons 
are projecting to thalamus and forebrain. Furthermore, there are some cholinergic interneurons in the 
cortex (72). 
 
In the cholinergic system two receptor types binding ACh are involved: the nicotinic and the muscarinic 
receptor type. The nicotinic receptor is an ionotropic receptor which forms an ion channel across the 
membrane and gets stimulated by ACh and nicotine. The muscarinic receptors forms part of the 
metabotropic receptor group. This receptor group is also referred to as G protein-coupled group, as 
metabotropic receptors use the G protein as second messenger. The subunits (α, β, γ) of the trimeric 
G protein are involved in cell signalling pathways. The name of the muscarinic receptor as well derives 
from the substance it gets stimulated from, apart from ACh: muscarine (87).  
Both of them are involved in regulation of a range of cell physiological activities including proliferation, 
differentiation and apoptosis (88). Muscarinic (89) as well as nicotinic (90) receptors, are present in the 
cortex in great number. 
 
One of the environmental pollutants interfering with the cholinergic system is MeHg. There are three 
main forms of interaction between MeHg and the cholinergic system: Firstly, there is evidence that 
micromolar MeHg concentrations block ACh receptors (91). Secondly, it has been shown that MeHg 
causes an activity reduction in acetylcholinesterase (92) and thirdly, has been demonstrated that 
MeHg increases release of ACh (93). 
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1.9 DA and its Importance in the Central Nervous System 
The name of the neurotransmitter DA derives from 3,4-dihydroxyphenethylamine and forms part of 
the catecholamine group (catecholamines are molecules that have a catechol, which is a benzene ring 
with two hydroxyl groups). It is synthesized by an enzyme called tyrosine-hydroxylase, which is present 
in every catecholaminergic neuron. This enzyme catalyses the transformation of the amino acid 
tyrosine to L-DOPA. Consequently, the enzyme dopa-decarboxylase is the catalyst for the L-DOPA to 
DA reaction (87). 
 
There are mainly two areas in the brain with dopaminergic neurons projecting to various areas of the 
brain. One originates in the substantia nigra in the mesencephalon projecting to the striatum, which 
comprises nucleus caudatus and putamen. The other dopaminergic system is located in the 
mesencephalon too, adjacent to the substantia nigra, and is called ventral tegmental area (VTA). The 
axons of the VTA are projecting to the frontal cortex and parts of the limbic system (87).  
DA from the nigrostriatal area plays an important role in movement control (94) whereas dopaminergic 
neurons from the ventral tegmental area are essential for reward (95). A lack or excess of DA is related 
to several illnesses such as restless legs syndrome (96), attention deficit hyperactivity disorder (97), 
schizophrenia (98) as well as PD (69). 
 
In the dopaminergic system, there are five subtypes of DA receptors. All of them belong to the G 
protein-coupled receptors. Those subtypes either belong to the D1-like group, including the subtypes 
D1 and D5, or to the D2-like family, comprising D2, D3 and D4. Those two groups differ from each other 
on behalf of their mode of action after activation by DA. The D1-like receptors are coupled with the 
adenylate cyclase stimulating Gs protein, whereas the D2-like family is attached to the adenylate 
cyclase inhibiting Gi protein, which is illustrated in figure 5. Activation of either Gi or Gs and the 
consequent effect on cAMP production leads to inhibition or stimulation of various cell signalling 
pathways that influence cell survival (99). 
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FIG. 5. Depiction of D1 and D2 receptors and their location in synapse and the nerve terminal. D1 receptors are 
coupled to stimulating Gs proteins that increase the production of the second messenger cAMP. D2 receptors are 
coupled to the inhibitory Gi protein which reduces cAMP production and can lead to hyperpolarization of the 
neuron. On the nerve terminal, D2 receptors can be found as well. Those receptors are autoreceptors and are 
associated with Gi too and regulate the dopamine release. Activation of autoreceptors occurs only at high DA 
concentrations, whereas post-synaptic DA receptors are much more sensitive (99). Figure from Cooper et al. 
(1991) (99). 
 
DA receptor location in the brain and number is varying: In rat cortex, D1 is the most numerous DA 
receptor and together with the less expressed D5 receptors, occurs in virtually all parts of the brain in 
varying concentrations. D2 receptors are the second most frequent DA receptors and occur in the 
forebrain too. D3 and D4 receptor presence in the cortex is limited. (100). 
 
In our project we focused on the effect of the D2 receptor. Therefore, the D2-like receptor family will 
be described briefly in the following: The inhibitory effects of the Gi protein of the D2-like receptor 
family resemble much each other. But D2-like receptor signalling is not limited to the Gαi-subunit-
induced reduction in cAMP levels. Their Gβγ-subunits is also involved in inhibiting various Ca2+ channels 
and in activating inwardly rectifying potassium channels which leads to hyperpolarization of the cell. 
Furthermore, a protein complex can assemble at the D2 receptor and induce further signalling with a 
big variety of targets (101). 
 
These signalling functions and the whole dopaminergic system can be affected by exposure to 
environmental pollutants, including MeHg and organochlorines. MeHg affects the dopaminergic 
system in several ways: There is evidence that 1µM Hg2+ prevents binding of a D1 receptor antagonist 
(102). Furthermore, it has been demonstrated that MeHg affects in in vivo studies the binding activity of 
D2 receptors (103). Additionally, a study by Zimmer et al. (2011) (104) showed that the exposure of 
developing neurons to MeHg affects neurotrophic factor levels that are important for the development 
of catecholaminergic cells. This leads to a reduced number of catecholaminergic neurons, including 
dopaminergic neurons. 
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Among the used organochlorine compounds PCBs and 4,4’-DDE might exert negative influence on 
the dopaminergic system: PCBs seem to affect the uptake of DA (105) and DA synthesis (106). 4,4’-DDE 
as well inhibits uptake of DA via the DA transporter (107).  
 
1.10 Objectives and Hypothesis 
This project was about studying potential neurotoxic effects of MeHg in combination with 
organochlorine pollutants on developing cortical neurons derived from a primary culture. We 
hypothesized that we would find increased cytotoxicity when cortical neurons were exposed to a 
MeHg-organochlorine combination, compared to cells exposed to MeHg alone. Furthermore, we 
wanted to investigate underlying mechanisms of a potential cytotoxic effect. Thus, we researched 
mechanisms known to be involved in cell viability decreasing effects of MeHg and organochlorines in 
order to find interactive effects of this MeHg-organochlorine combination. These mechanisms included 
ROS production, GSH levels and mitochondrial membrane potential. Additionally, we extended our 
research on how the absence or presence of neurotransmitters involved in PD (ACh and DA) would 
affect neurons exposed to a MeHg-organochlorine combination. This branch of our investigation was 
based upon a literature finding that demonstrated that developmental exposure to MeHg decreased 
the number of dopaminergic neurons (104). Loss of dopaminergic neurons is characteristic for PD, thus, 
an already reduced number in dopaminergic neurons might increase the probability of developing PD. 
Furthermore, a reduced number of cortical neurons is associated with PD (66) too. So we decided to 
investigate the influence of dopamine on immature cortical neurons if co-exposed to MeHg 
and organochlorines. We were interested in whether we could detect an interactive effect in cells 
exposed to the MeHg and organochlorines, if co-exposed to sub-toxic concentrations of DA. As PD is 
based upon a DA-ACh imbalance (78), we investigated a possible interactive effect of a sub-toxic ACh 
concentration with MeHg as well. We hoped that our results would help to elucidate cytotoxic 
mechanisms of environmental toxicants and would support previous findings related to the impact of 
MeHg and organochlorines on PD development. 
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2 MATERIALS AND METHODS 
2.1 Materials 
TABLE 3: Supplier of used material and further information  
Animals Supplier Reference Number 
Pregnant NMRI strain mouse 
at 16th day of pregnancy 
Charles River Laboratories, Iffa 
Credo (Saint Germain-sur-
l’Arbreste, France) 
 
Compound   
 Sigma Aldrich, St. Louis (MO  
Antimycin A  A8674 
BSO (DL-buthionine-[S,R]-
sulfoximine) 
 B2640 
DMSO (Dimethyl sulfoxide) 
99.5% GC 
 D5879 
DNAse  D5025 
H2DCF-DA (2´,7´-
Dichlorofluorescin diacetate) 
 D6883 
L-Glutamic Acid (L-Glutamate) 
Monochlorobimane 
 
(Fluka Analytical) 
G-8415 
69899 
Paraformaldehyde  P6148 
Poly-D-lysine hydrobromide 
Rhodamine 123 
 
 
R8004 
Sodium dodecyl sulfate (SDS)  L4509 
Resazurin sodium salt  R7017 
Thiazolyl Blue Tetrazolium 
Bromide (MTT) 
 M2128 
Triton 100x        X100 
Uridine    
Dulbecco’s MEM (10x) 
w/ 4.5 g/L D-Glucose 
Biochrom AG F0455 
Halothane 
Propidium iodide 
Zeneca – Fluothane 
EMD Chemicals 
615179 
537059 
Toxicants   
 Sigma Aldrich  
Dieldrin (Pestanal) 33491 
Hexachlorobenzene 
Methylmercury(II) chloride 
 
 
171050 
442534 
PCB No. 153 (Fluka Analytical) 35602 
 Dr. Ehrenstorfer  
4,4’-DDE  C12041000 
PCB No. 138  C200138001 
Neurotransmitter           and  Antagonist  
 Sigma Aldrich  
Acetylcholine chloride  A6625 
Dopamine hydrochloride  H8502 
S(-)-Raclopride (+)-tartrate salt  R121 
Antibodies   
   
 Sigma Aldrich, Israel  
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Mouse monoclonal anti- Glial 
Fibrillary Acidic Protein (GFAP) 
Antibody 
 G3893 
Rabbit polyclonal anti-Tau 
Antibody 
 080M4753 
 
Invitrogen, Molecular Probes, 
Life Technologies, Oregon, USA 
 
Alexa Fluor 488 Goat Anti-rabbit 
IgG Secondary Antibody 
 A11008 
Alexa Fluor 594 Donkey Anti-
goat IgG Secondary Antibody 
 A11058 
Alexa Fluor 594 Goat Anti-
mouse IgG Secondary Antibody 
 A11032 
Materials   
 
Thermo Scientific Nunc, 
Denmark 
 
Nunclon Delta surface 24-well 
plates 
 142475 
Nunclon Delta surface 96-well 
plates 
 167008 
   
Other material and compounds were obtained from the institution’s suppliers (Sigma Aldrich and Merck). 
 
2.2 Used Mixtures and Buffers 
TABLE 4: Mixtures applied for preparations of toxicants, reagents and washing. 
Mixture Composition 
Nanopure Water Milipore miliQ synthesis A10 – 18.2 MΩ*cm; 3 ppb COT 
Used to make all solutions and dilutions 
Hank’s Buffer solution 1.3 mM CaCl2·2H2O, 5.4 mM KCl, 0.4 mM KH2PO4, 0.5 mM, 
MgCl2·6H2O, 0.4 mM MgSO4·7H2O, 137 mM NaCl, 4.2 mM 
NaHCO3, 0.3 mM Na2HPO4·2H2O, 8 mM HEPES, 5.5 mM 
Glucose-H2O; adjusted to pH 7.4 
Krebs Buffer 120.9 mM NaCl, 4.83 mM KCl, 1.22 mM KH2PO4, 25.5 NaHCO3, 
13 mM Glucose , Phenol Red ( approx. 0.015 g/L) 
Phosphate buffered saline (PBS) 
solution 
135 mM NaCl, 7.5 mM Na2HPO4·2H2O, 1.5 mM KH2PO4, 2.7 mM 
KCl; pH 7.4 
  
 
2.3 Instruments 
TABLE 5: Instruments used for experimental assays and preparing primary cultures  
Instrument Model  Software 
Fluorescent confocal microscope Leica Microsystems DM5500 Q Leica Application Suite 
Advanced Fluorescence (LAS 
AF) 
Fluorometer Molecular Devices Spectramax 
Gemini XS 
SOFTmax PRO Software 
Phase-contrast microscope Leica Microsystems DMI4000 B 
Camera: Leica DFC 300 FX 
Leica Application Suite V3 
Spectrometer Thermo Electron Corporation 
Multiskan Spectrum 
SkanIt RE for MSS 2.2 
Equipment in Cell Culture 
Laboratory  
In-house service: including 
centrifuges, incubators, phase-
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contrast microscope, laminar 
flow horizontal and vertical 
hoods 
Equipment in General Laboratory   
Animal Facility University of Barcelona, School 
of Medicine 
 
   
 
2.4 Toxicants 
Toxicants were used alone, in combination or as mixtures to research their impact on toxicant-induced 
alterations in developing cortical neurons derived from a primary culture.   
 
2.4.1 Selection of MeHg Concentrations 
The experimental concentrations of MeHg were adjusted from concentrations of previous experiments 
relevant to this investigational aims. The previously used MeHg concentrations ranging from 0 – 1000 
nM were used at the double of the cell concentration (1.6*106 cells/ml) of what was used in this 
project, i.e. 8*105 cells/ml. These concentrations proved to be too high for the used cell density 
resulting in rapid cell death. Thus, cells could not be exposed over a longer period of time to study 
chronic effects of MeHg. So we chose to use lower concentrations for the chronic exposure, with a 
maximum of 300 nM. 
For acute assays (ROS, GSH levels and ΔΨm assays) higher MeHg concentrations were chosen. In acute 
assays shorter exposure times were used. Due to shorter exposure time, MeHg concentrations were 
used at higher concentrations. 
 
2.4.2 Selection of Organochlorine Pollutants (OCPs) Concentrations 
The concentration of the seven organochlorine compounds used in this project were based upon 
findings of Briz et al. (2010) (47) and previous relevant experiments for dieldrin,  and on the INMA Project 
Valencia mother-infant cohort study (108), (109) for 4,4’-DDE, β-HCH, δ-HCH, HCB, PCB-138 and PCB-153. 
The INMA project is a study involving several research groups in Spain with the aim to investigate the 
impact of the environmental pollutants on children. Concentrations were used at 10 or 100 times of 
the geometric mean (GM) values of concentrations detected in cord blood of the INMA project and 
are summarized in table 6. 
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TABLE 6: Organochlorine toxicant concentrations found in samples of cord blood in the INMA project 
OCP compound Geometric Mean 
(GM) Values 
(ng/ml) 
100x GM Values 
(ng/ml) 
100x GM Values 
(nM) 
10x GM Values 
(nM) 
4,4’-DDE 0.82 82 258 25.8 
HCB 0.29 29 102 10.2 
β-HCH 0.12 12 41 4.1 
δ-HCH 0.023 2.3 7.9 0.79 
PCB-138 0.1 10 28 2.8 
PCB-153 0.13 13 36 3.6 
 
4,4’-DDE, β-HCH, HCB, PCB-138 and PCB-153 were used as mixture, while δ-HCH was not, due to its 
low concentration in the cord blood samples. Dieldrin was not added to the mixture as it was not 
investigated in the INMA study.  
From now on, if a “POPs mixture” is mentioned, it is referred to a mixture of 4,4’-DDE, β-HCH, HCB, 
PCB-138 and PCB-153. 
 
2.4.3 Selection of Neurotransmitter and Antagonist Concentrations 
DA concentrations for determining a sub-toxic dose were chosen from 100 µM of DA downwards based 
on a study by Noh et al. (1999) (110) demonstrating that 100 µM DA cause cell mortality.  
The experimental concentration of 100 µM ACh was chosen based upon previous experiments relevant 
to this investigational aim  that demonstrated that 100 µM is a sub-toxic ACh concentration. 
Raclopride concentrations were chosen following the product data sheet of Abcam suggesting an IC50 
of D2 receptor inhibition at 32 nM. 
 
2.5 Stock Solutions Preparation and Toxicant Treatment  
MeHg, organochlorine reagents, neurotransmitter and antagonist solids were weighed and dissolved 
in H2O (MeHg and ACh), ethyl acetate (HCB) or DMSO (4,4’-DDE, β-HCH, δ-HCH, HCB, PCB-138, PCB-
153 and raclopride), portioned as 50 µl aliquots and stored in the freezer at -20°C. Fresh aliquots were 
used for every new treatment solution and further prepared as needed. 
With these solutions cortical neurons were treated and exposed over varying times. DMSO and ethyl 
acetate, which were used to dissolve compounds, never exceeded 0.5% per well if exposed chronically. 
These concentrations proved not to be cytotoxic to primary culture cortical neurons. 
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2.6 Cortical Neuronal Cultures 
The cerebral cortex is involved in crucial functions of the human brain, including motor and sensory 
functions and cognition. The cytotoxic effects of MeHg are strongly exhibited in the cerebral cortex 
which is also one of the most susceptible brain regions to organochlorines (111). Additionally, neurons 
are the most susceptible brain cells regarding MeHg toxicity (17). That’s why we chose to culture 
cortical neurons which were isolated from 16-day old mouse foetuses. Foetuses were used at day 16 
of pregnancy, because at that time mouse neurons are not differentiated yet and are close to their 
last separation by mitosis, resulting in a more pure culture (112). The maturation of the neurons is 
expressed as days in vitro (DIV), starting at the day after seeding and indicating the age of the cell 
culture. 
Primary cultures of cortical neurons were isolated from the cerebral cortices of 16-day-old NMRI 
mouse foetuses. Halothane was used to anesthetize pregnant mice which were sacrificed by cervical 
dislocation. The foetuses were extracted by forceps and the cerebral cortices were removed in a sterile 
hood. The cortices were cut with a razorblade and transferred to a mixture of Krebs buffer, bovine 
serum albumin (1.2% w/v) and MgSO4 (150 mM). Consequently, brain tissue was hydrolysed at 37°C 
for 20 minutes by a solution containing trypsin (0.02% w/v) to dissociate cells and DNAse (0.0075% 
w/v) which should reduce freely floating DNA. Soybean trypsin inhibitor (0.052% w/v) stopped 
trypsinization. A syringe was used to mechanically disaggregate cells to obtain a single cell suspension.  
The cell suspension with a density of 8*105 cells/ml was prepared in adapted DMEM medium (10% 
fetal bovine serum, 0.2% penicillin, 26.2 mM NaHCO3, 25mM glucose, 0.2 mM L-glutamine, 100 mU/l 
insulin, 7 µM p-aminobenzoic acid). This cell suspension was seeded at a density of 8x105 cells/ml in 
24- or 96-well plates previously coated with poly-D-lysine (50 mg/L). The cultivation of the plated cells 
took place in a humidified incubator at 37°C with a 5% CO2/ 95% air mixture. To avoid astrocyte growth, 
the antimitotic compound uridine (20 µM) was added on DIV1. Animal handling was done according 
to standard procedures at the University of Barcelona, which were approved by the Generalitat de 
Catalunya, Spain and are according to EU guidelines. 
 
2.7 Experiments for Assaying Cell Viability 
By measuring the formazan product of the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), the MTT assay was used to quantify cell viability. Reduction of the 
MTT dye to formazan occurs by reduction of mitochondrial enzymes. The MTT solution was prepared 
in Hank’s buffer at the concentration of 5mg/ml and added to each well of cells at a 10% v/v 
concentration. Plates were incubated for 2.5 hours at 37°C, protected from light, before the content 
of the wells was discarded. Next, 100 µl of 10% sodium dodecyl sulphate (SDS) were added to lyse the 
cells and dissolve the formazan and consequently incubated for at least four hours in an incubator at 
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37°C. Spectrophotometry was used to quantify the absorbance of the formazan product in a 
spectrometer at 560 nm.  
 
The resazurin assay was also used to quantify cell viability, in this case, by measuring the fluorescence 
of resorufin, a fluorescent product of the non-fluorescent resazurin. The reduction of resazurin occurs 
due to the cell´s redox potential, which the cell needs for metabolic activity (113). The resazurin solution 
was prepared at a concentration of 100 µg/ml in phosphate buffered saline (PBS) and added at a 10% 
v/v concentration to the seeded cells. Cells were incubated for 2 hours at 37°C to allow them to convert 
resazurin to resorufin. The fluorescence (Ex 530 nm/Em 590 nm) of resorufin was quantified in a 
fluorometer.  
 
The propidium iodide (PI) assay was the third method to assess cell viability: PI is membrane-
impermeable and intercalates with DNA. Thus, PI will intercalate only with DNA of cells which have 
already permeabilized membranes and therefore stains damaged cells. If intercalated with DNA, the 
excitation and emission wavelengths of unbound PI shift to the below-mentioned excitation and 
emission wavelengths of bound PI. The PI solution was prepared at a concentration of 40 µg/ml in PBS 
and added at 2% v/v concentration to the seeded cells. 30 minutes before adding the PI solution 10% 
Triton-X was added to negative control cells to lyse the cells. Next, PI solution was added and incubated 
for 30 min at 37°C to allow PI to intercalate with intracellular DNA. The fluorescence (Ex 535 nm/Em 
617nm) of intercalated PI was quantified in a fluorometer. 
 
2.8 Immunocytochemistry for Cell Morphology  
Immunocytochemistry was used to get a qualitative image of cells exposed to various toxic 
compounds. For immunocytochemistry cells were seeded in 24-well plates. After discarding the 
solutions of the plate, 4% paraformaldehyde (PFA) was added for 10-15 min to fix the cells. PFA was 
removed from the plate and cells were washed three times for 5-10 min with PBS. Cell membranes 
were permeabilized with 0.15% v/v triton-PBS for 15 min to allow antibodies to enter. Blocking 
unspecific binding sites was done by incubating cells with 1% w/v BSA-PBS for 1 hour. Primary 
antibodies were diluted in 0.1% w/v BSA-PBS, 1:500 rabbit polyclonal anti-Tau and 1:1000 mouse 
monoclonal anti-GFAP antibodies, and added to the plate. Incubation of the cells with the primary 
antibodies was done in agitation at 4°C overnight. On the following day, cells were washed three times 
with PBS for 5-10 min. Secondary antibodies were diluted in 0.1% w/v BSA-PBS, 1:1000 green goat anti-
rabbit IgG and 1:1000 red goat anti-mouse IgG antibodies. Cells were incubated with secondary 
antibodies at room temperature for 1 hour protected from light. Next, cells were washed one time 
with PBS for 5-10 min and incubated with 5 µM bisbenzimide (nuclear dye) in PBS for 5-10 min and as 
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final step washed with PBS for 5-10 min. A phase-contrast fluorescence microscope was used to see 
the stained cells at a 200x magnification. Five fields per well were photographed with the help of Leica 
Application Suite V3 software of which a representative picture was chosen. 
 
2.9 Oxidative Stress Assays 
To assess production of oxidative stress in cortical neurons, the fluorescence of oxidized 2’,7’-
dichlorodihydrofluorescin diacetate (H2DCF-DA) was measured. The non-fluorescent H2DCF-DA 
penetrates cells and gets oxidized by reactive oxygen species (ROS) converting it to the fluorescent 
2',7'-dichlorofluorescein (DCF). The H2DCF-DA stock solution was prepared at a concentration of 2 mM 
(1 mg/ml) in methanol and diluted to 10 µM in Hank’s buffer. In the chronic assays, cells chronically 
exposed to the compounds were rinsed two times with Hank’s buffer and incubated with the 10 µM 
H2DCF-DA solution for 20 min at 37°C protected from light. Cells were rinsed again for two times with 
Hank’s buffer and previously prepared H2O2 concentrations in Hank’s buffer were added. Next, 
fluorescence of DCF (Ex 492 nm/Em 525 nm) was measured by a fluorimeter. Measurements were 
taken every 5 minutes until 30 min and then every 30 min. 
In the acute assays, the same procedure was performed, but instead of adding the H2O2 solution, 
toxicant solutions were added to the cells.  
 
For assessing how GSH levels are involved in oxidative stress, quantification of GSH levels was done via 
measurement of fluorescent monochlorobimane (mBCl). mBCl is not fluorescent until conjugated with 
GSH. 10 mM DL-buthionine-[S-R]-sulfoximine prepared in PBS were added 24 hours previous to the 
GSH determination as negative control, to inhibit GSH synthesis and incubated at 37°C. The next day, 
compounds that should be tested for GSH depletion were added to cells and incubated for 60 minutes 
at 37°C. Next, 8 mM mBCl was added and incubated for 30 minutes at room temperature and 
protected from light. The fluorescence (Ex 360 nm/Em 460 nm) of the conjugated mBCl was quantified 
via a fluorimeter.  
 
2.10 Mitochondrial Membrane Potential (ΔΨm) 
To quantify mitochondrial membrane potential (ΔΨm) fluorescent rhodamine 123 was used. 
Rhodamine can enter mitochondria but its fluorescent gets quenched by mitochondrial energization. 
A 10 mM rhodamine 123 stock solution was prepared in dimethyl sulfoxide (DMSO) and was diluted 
1:10 in Hank’s buffer. Cells were rinsed two times with Hank’s buffer, then, the rhodamine 123 dilution 
was added to the cells and incubated for 15 min at 37°C. Cells were rinsed three times with Hank´s 
buffer and various concentrations of the compounds to be tested, prepared in Hank’s buffer, were 
added. As negative control, 30 µM anitmycin A, an inhibitor of the respiratory chain, were added. The 
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fluorescence (Ex 485 nm/Em 530 nm) of non-quenched rhodamine 123 was quantified by a 
fluorimeter. Measurements were taken every 5 min until 30 min and then at 60 min. As control 
condition, 2% triton X was added after 60 min to the cells and incubated for 15 min at 37°C to lyse 
cells.  
 
2.11 Statistical Analysis of Data 
Obtained data were organized and analysed with Microsoft Excel 2007 and subsequently analysed and 
visualized with Graph-Pad Prism version 4.0 and 6.0 software (GraphPad Software Inc., San Diego, CA). 
Data are represented in bar graphs with mean ± SEM. When no statistically significant difference of 
the basal control values (i.e. the values of the treatment groups at 0 concentration of the toxicant that 
is plotted at the x axis of the graph) was found, each treatment condition was normalized to their basal 
control values to make a comparison among the groups easier and focus on possible interactive effects. 
Results were analysed with a two-way ANOVA analysis followed by a Bonferroni multiple comparison 
post-test. 
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3 RESULTS 
3.1 Effects of Combined Exposure of MeHg and Single Compound OCPs on Viability 
To study the effects of combined MeHg and organochlorine exposure on differentiating neurons, cells 
were consequently exposed to the toxicants from the cortical neurons’ first day in vitro (DIV1). At this 
stage neurons are considered to be immature (112). 
The first experiments were done for two purposes. Firstly, we wanted to investigate whether OCPs in 
combination with MeHg exacerbate MeHg-induced effects on cortical neurons. Secondly, these 
experiments were also used to approve or adjust previously used MeHg working concentrations to a 
less dense cell culture of 8*105 cells/ml, which is half as dense as the previously used cell culture 
density.  
 
In the first trials, differentiating cortical neurons were exposed to 0-1000 nM MeHg alone or in 
combination with 60 nM dieldrin or 100 nM HCB. In the first experiments the used concentrations 
higher than 300 nM MeHg (600 nM and 1000 nM MeHg) proved to be too high to be exposed over a 
longer period of time. Hence, MeHg concentrations were changed to 0-300 nM and the same 
experiments were repeated. Cells were exposed to 0-300 nM MeHg in absence or presence of 60 nM 
dieldrin or 100 nM HCB for 6-8 days (DIV1 to DIV6-8), depending on the culture’s susceptibility to 
MeHg. 
 
In this experiment no statistically significant change in cell viability by dieldrin and HCB could be 
observed, thus every value of the MeHg-dieldrin condition was normalized to the value of 0 nM MeHg 
and 60 nM dieldrin. The same applied for HCB, where values were normalized to 0 nM and 100 nM 
HCB.  This was done to facilitate direct comparison in-between groups to focus on interactive effects. 
Furthermore, there is no statistically significant difference in cell viability when cells exposed to MeHg 
alone are compared to the combination of MeHg and dieldrin or MeHg and HCB, neither at sub-toxic 
or toxic MeHg concentrations, as can be seen in figure 6. No toxic effects of MeHg are observable until 
100 nM MeHg. Beginning at 200 nM MeHg, cell viability decreases by 30% and is further reduced at 
300 nM, reaching 60% of viability.  
The same pattern was found, when viability curves were evaluated by means of a resazurin assay (data 
not shown). 
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FIG. 6. Viability curve of cortical neurons after exposure to different MeHg concentrations alone or in 
combination with dieldrin or HCB. Primary culture cortical neurons were exposed to 0-300 nM MeHg in absence 
or presence of 60 nM dieldrin or 100 nM HBC from their first day in vitro (DIV1) to DIV 6-8. Viability was evaluated 
via MTT assay. The bars are expressed as a percentage of the MeHg-free basal control values. The data are 
represented as mean ± SEM and were obtained in three independent trials, using triplicates per treatment 
condition.  
 
As there were no significant interactive cytotoxic effects of dieldrin or HCB with MeHg at any 
concentration observable, we decided to screen some OCPs for interactive cytotoxic effects with MeHg 
at a sub-toxic concentration. We chose δ-HCH, 4,4’-DDE, PCB-138 and PCB-153, as this selection 
comprises a representative variety of different compound groups that belong to the compounds with 
the highest levels detected in infant cord blood in the INMA project (108), (109).  
 
Primary culture cortical neurons were exposed for 8 or 9 days (DIV1 to DIV8/9) to 100 or 200 times the 
geometric mean (GM) of each of the abovementioned organochlorines, in absence or presence of 50 
nM MeHg. By using 100x GM we compensated for the long-term exposure over months in real life, 
whereas by using 200x GM we wanted to determine whether the double of our working concentration 
would exhibits toxic effects. 
 
Neither, there was a statistically significant toxic effect of an OCP compound alone, nor was a 
statistically significant interactive toxic effect of one of the four OCPs with 50 nM MeHg observable. 
No effect was observed at 100x GM, nor at 200xGM concentrations, as shown in figure 7.  
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FIG. 7. Viability of cortical neurons after exposure to MeHg alone or in combination with an organochlorine 
compound at different concentrations. Cells were intoxicated either in absence or presence of 50 nM MeHg with 
100 or 200 times the geometric mean (GM) of δ-HCH (A), 4,4’-DDE (B), PCB-138 (C) and PCB-153 (D) on DIV1 and 
exposed until DIV8-9. The viability was evaluated via MTT assay. The bars are expressed as percentage of the 
value of 50 nM MeHg. The data are represented as mean ± SEM and were obtained in three independent trials, 
using triplicates per treatment condition.  
 
3.2 Effects of Combined Exposure of MeHg and POPs mixture on Viability 
Our next experiment was done to evaluate a possible interactive toxicity of a mixture of representative 
organochlorines, found at high levels in infant cord blood in the INMA project (108), (109), and MeHg. In 
this experiment sub-toxic and toxic MeHg concentrations in combination with a POPs mixture at 
different GM concentrations were used. The mixture comprises 4,4’-DDE, HCB, β-HCH, PCB138 and 
PCB153. From now on, the mixture comprising 4,4’-DDE, HCB, β-HCH, PCB138 and PCB153 will be 
referred to as “POPs mixture”.   
 
In this experiment cells were exposed consequently for 8-9 days (DIV1 to DIV8/9) to MeHg 
concentrations ranging from 0-300 nM and the mixture of OCPs at 10x GM and 100x GM 
concentrations. Neither, statistically significant toxic effects of the POPs mixture at 10x or 100x GM, 
nor statistically significant interactive cytotoxic effects between the different treatment conditions 
were found, as illustrated in figure 8.  
 
The results are supported by data which were obtained by evaluating the same experiments by means 
of a PI assay (data not shown). The obtained graph showed the same viability pattern as the assay done 
by MTT. 
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FIG. 8. Viability of cortical neurons after exposure to the POPs mixture and MeHg at different concentrations. 
Cells were intoxicated with MeHg concentrations in a range from 0-300 nM and the POPs mixture at 10x or 100x 
GM of HCB, β-HCH, 4,4’-DDE, PCB-138 and PCB-153 on DIV1 and exposed until DIV8-9. The viability was evaluated 
via MTT assay. The bars are expressed as a percentage of the MeHg-free basal control values. The data are 
represented as mean ± SEM and were obtained in three independent trials, using triplicates per treatment 
condition.  
 
To investigate whether the MeHg concentrations of acute assays influence cell viability, cells were 
exposed on DIV7/8 for 24h (which is longer than actually needed for acute assays) to MeHg (up to 1 
µM) and the 100x GM POPs mixture. No statistically significant decrease in cell viability could be found 
in any of the treatment conditions. The experiments were evaluated by PI and MTT assay and were 
realized in two independent trials, using triplicates per treatment condition (data not shown).  
 
We were not only interested in qualitative viability assays but we also wanted to investigate the quality 
of the neuronal culture exposed to toxicants. Immunostains can provide interesting qualitative 
information about cell morphology. We were interested in possible differences in cell morphology, 
comparing cells with different treatment conditions (MeHg alone and in combination with the POPs 
mixture). Although we did not find any statistically significant difference in cell viability, we decided to 
make cell morphology visible by immunocytochemistry, as MeHg (59) and PCBs (60), (61) are supposed to 
have the ability to interfere with microtubules and thus change cell morphology. 
 
Cortical neurons from primary cultures were exposed to MeHg at 0, 50 and 100 nM alone or in 
combination with the POPs mixture at 100x GM concentrations for 8 days (DIV1-8) and consequently 
fixed. To make neurons and astrocytes visible, we stained the cells with antibodies for Tau and GFAP. 
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Tau is a protein that is bound to the microtubules of neurons and GFAP occurs specifically in astrocytes. 
The fluorescent stain bisbenzimide was used to stain the nuclei of the cells. 
 
Neuronal cell bodies and a dense neurite network are well observable due to the Tau 
immunofluorescence. Cell density and neurite network density decreases with increasing MeHg 
concentrations, showing no difference between treatment conditions except for cells at 100 nM MeHg, 
where a slight difference between the two different treatment conditions is observable. The cells 
exposed to MeHg alone at 100 nM seem to be less susceptible than those where the additional 100x 
GM POPs mixture was added which can be seen in figure 9. 
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FIG. 9. Fluorescence microscopy images of Tau-immunostained cortical neurons from primary cortical neuronal 
cultures. Only neurons (at DIV8) immunostained with Tau are depicted here, as astrocytes, stained with GFAP, 
and nuclei, stained with bisbenzimide, are not shown for clarity. Neurons were either left untreated (A), exposed 
to 50 nM MeHg (B), 100 nM MeHg (C), 100x GM POPs mixture (D), 50 nM MeHg and 100x GM POPs mixture (E) 
or 100 nM MeHg and 100x GM POPs mixture (F). Decreasing cell body density and neurite density with increasing 
MeHg concentrations are observable. One image was chosen from five regions per well, with one well per 
condition. The images were taken at a 200x magnification.   
 
3.3 Effects of Combined Exposure of MeHg and POPs on Oxidative Stress 
Studies by Francoa et al. (2009) (53) and Shinyashiki et al. (1996) (114) have demonstrated that enzymes 
important for protection against oxidative stress can be inhibited by MeHg, including the ROS-
neutralizing enzymes glutathione peroxidase and superoxide dismutase. In this experiment we wanted 
to investigate whether the chronic and combined exposure of MeHg and dieldrin or MeHg and HCB 
would exhibit a difference in ROS production if compared to cells exposed to MeHg only. In this assay 
we used a sub-toxic MeHg concentration to study the influence on ROS production in the cells. 
  
Cortical neurons were left alone or exposed to sub-toxic 50 nM MeHg and 60 nM dieldrin (each 
compound alone and in combination) for 6 to 8 days, depending on the culture’s susceptibility. On the 
last day of exposure the assay was performed by adding increasing hydrogen peroxide (H2O2) 
concentrations to induce oxidative stress and investigate if cells exposed to the toxicant combination 
would exhibit increased ROS production compared to untreated cells or cells exposed to single 
compounds. The same experiment was also performed with 100 nM HCB, instead of 60 nM dieldrin. 
 
In this experiment, it has been demonstrated that there is no statistically significant difference 
between cells exposed to different treatment conditions. As there was no statistically significant 
difference between the treatment groups without H2O2, their values were normalized to each of their 
H2O2-free condition to facilitate in-between comparison among groups. 
  
35 
 
The same results were obtained when the experiment was realized with 100 nM HCB instead of 
dieldrin. Both graphs are shown in figure 10. 
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FIG. 10. Effect of MeHg alone or in combination with organochlorine pesticides dieldrin or HCB on ROS 
production. Cells were intoxicated with 50 nM MeHg and 60 nM dieldrin (A) or 100 nM HCB (B) on DIV1 and 
exposed until DIV6-8 when H2O2 at different concentrations was used to induce oxidative stress in mature cells. 
Reactive oxygen species were measured via DCF fluorescence at 30 minutes after adding hydrogen peroxide. The 
bars are expressed as a percentage of the H2O2-free basal control values. The data are represented as mean ± 
SEM and were obtained in three independent trials using triplicates per treatment condition.  
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Next, we investigated the acute effects of chronically toxic MeHg concentrations (up to 1 µM) in 
combination with the 100x GM POPs mixture on oxidative stress. We used a ROS assay (on DIV6/7), to 
investigate a possible induction or increase of oxidative stress, and measured GSH levels (DIV2 and 
DIV8), as GSH plays an important role in neutralizing ROS. In both experiments we could not find any 
observable, statistically significant effects. 
Both experiments were realized in two independent trials, using triplicates per treatment condition 
(data not shown).  
  
3.4 Effects of Combined Exposure of MeHg and POPs mixture on ΔΨm 
Because of studies suggesting the involvement of the mitochondria as one possible mechanism for the 
neurotoxicity of MeHg (46) and for the harmful effects of POPs on mitochondria (42), (43), we decided to 
do an experiment investigating mitochondrial function at combined exposure of MeHg and the POPs 
mixture. 
 
Primary cultures of cortical neurons were exposed at DIV 7-8 to the 100x GM POPs mixture in absence 
or presence of MeHg concentrations ranging from 0 to 1000 nM. 30 μM of antimycin A were used as 
positive control, leading to mitochondrial membrane depolarization of nearly 200%.  
 
We found a tendency that increasing MeHg concentrations lead to an increased level of depolarized 
mitochondrial membranes, as well as cells exposed to the 100x GM POPs mixture alone, tend to 
depolarize the inner mitochondrial membrane too. When primary cultures were exposed to both, 
MeHg and the mixture, the depolarization by the POPs mixture on its own is statistically significant 
different (p < 0.05) from the control value without MeHg and POPs mixture. Furthermore, statistically 
significant (p < 0.01) interaction between the two treatments was found. The tendency of the POPs 
mixture to depolarize the mitochondrial membrane seems to be increasingly counteracted by 
increasing MeHg concentrations. In combination, the depolarizing effect of the POPs mixture seems to 
be negatively correlated with the MeHg concentrations, as can be seen in figure 11. 
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FIG. 11. Mitochondrial membrane depolarization in cortical neurons after MeHg and 100x GM POPs mixture 
exposure. On DIV 7-8 cells were exposed to MeHg concentrations at 0, 50, 600 and 1000 nM in absence or 
presence of the POPs mixture at concentration 100x GM, and to 30μM antimycin A as positive control. Levels 
were measured via rhodamine 123 fluorescence at 60 minutes after addition of the reagents. The bars are 
expressed as a percentage of the control basal value. The data are represented as mean ± SEM and were obtained 
in three independent trials using triplicates per treatment condition. Statistical significance marked as * (p < 0.05) 
compares the difference between cell exposed to MeHg only and cells exposed to MeHg and the OCP 100x 
mixture. Statistical significant (p < 0.01) interaction was found between the two treatments. 
 
3.5 Effects of Combined MeHg-ACh Exposure on Viability 
We used the sub-toxic ACh concentration of 100 µM, to investigate possible interactive effects with 
sub-toxic and toxic concentrations of MeHg. The sub-toxic ACh concentration was determined in 
previous experiments relevant to this investigational aim.  
 
Neuronal cells from the primary culture were exposed from DIV1 for 5-6 days to MeHg alone at 
concentrations ranging from 0-300 nM or in combination with 100 μM ACh.  
 
In this experiment it could be proven that 100 µM do not exhibit any toxic effect on the used cell 
culture. For this all MeHg-100 µM ACh values were normalized to the ACh only-value to facilitate in-
between treatment comparison. But, as seen in figure 12, ACh was found to statistically significant 
increase cell mortality in combination with 100 nM MeHg. 
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FIG. 12. Concentration dependent viability of cortical neurons after exposure to MeHg alone at different 
concentrations or in combination with ACh. Cells were exposed to MeHg concentrations in a range from 0-300 
nM and 100 μM ACh from DIV1 to DIV5-6. The viability was evaluated via MTT assay. Bars are represented as 
percentage of MeHg-free basal control values. The data are represented as mean ± SEM and were obtained in 
three independent trials, using triplicates per treatment condition. Statistical significance is marked as *** (p < 
0.001). 
 
3.6 Effects of Combined MeHg-DA Exposure on Viability 
Cortical neurons were exposed for 5-7 days (DIV1-5/7) to DA at concentrations ranging from 10-100 
μM, in presence or absence of 50 nM MeHg.  
 
Figure 13 shows that concentrations up to 10 µM DA, in combination with MeHg or not, do not exhibit 
any statistically significant effect on cell viability, whereas from 30 µM on, cell mortality increases from 
40% at 30 µM DA up to 80% at 100 µM DA.  
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FIG. 13. Concentration dependent viability of cortical neurons after exposure to different concentrations of DA 
in absence or presence of 50 nM MeHg. Cells were exposed to DA concentrations in a range from 0-100 µM alone 
or in presence of 50 nM MeHg from DIV1 to DIV5-7. The viability was evaluated via MTT fluorescence.  Bars are 
represented as percentage of the MeHg- and DA-free basal control value. The data are represented as mean ± 
SEM and were obtained in three independent trials, using triplicates per treatment condition.  
 
Based on the previous finding the working concentration was set to the sub-toxic concentration of 10 
µM DA and was used to further investigate the effect of this DA concentration on various MeHg 
concentrations, including toxic ones. 
 
Cortical neurons were exposed for 6-8 days (DIV1 - DIV6/8) to 10 µM DA in presence or absence of 
various MeHg concentrations ranging from 0-300 nM.  
 
As already proven above, 10 µM proved not to be toxic alone, hence MeHg-DA values were normalized 
to the DA alone-value. As can be seen in figure 14, 10 µM DA statistically significant increased cell 
viability at toxic MeHg concentrations. As shown in figure 16, at 100, 200 and 300 nM a viability 
increasing effect of DA could be observed. At 200 nM MeHg viability was increased up to 30%.  
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FIG. 14. Concentration dependent viability of cortical neurons after exposure to different concentrations of 
MeHg alone or in combination with 10 µM DA. Cells were exposed to MeHg concentrations in a range from 0-
300 nM and 10 µM DA from DIV1 until DIV6-8. The viability was evaluated via MTT assay. The bars are 
represented as percentage of the MeHg-free basal control values. The data are represented as mean ± SEM and 
were obtained in three independent trials, using triplicates per treatment condition. Statistical significance is 
marked as ** (p < 0.01) and *** (p < 0.001). 
 
 
3.7 Mechanisms involved in the Protective Effect of DA against MeHg toxicity 
As MeHg and organochlorines compounds are suspected to be involved in inducing excitotoxicity (see 
section 1.4.2), we investigated a possibly increased susceptibility to glutamate-induced excitotoxicity.  
 
Primary culture cortical neurons were exposed for 5 days (DIV1-5) to 50 nM MeHg in absence or 
presence of 10 µM DA. On DIV5 glutamate concentrations (0-600 µM) were added and exposed for 
another 2-4 days, depending on the culture’s vulnerability.  
 
As none of the treatment conditions exhibited toxic effects at 0 µM glutamate they were normalized 
to each of their basal control values. No statistically significant differences could be observed regarding 
the treatment: Cells exposed to MeHg were not more susceptible to glutamate-induced excitotoxicity 
than naïve ones, nor did 10 µM DA statistically significant increase cell viability, regardless of the 
presence of 50 nM MeHg. After 2-4 days of exposure to glutamate, cell-viability was reduced up to 
40% at 600 µM glutamate, as can be seen in figure 15. 
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FIG. 15. Concentration dependent viability of cortical neurons after exposure to 50 nM MeHg alone or in 
combination with 10 µM DA and consequent exposure to different glutamate concentrations. Cells were exposed 
to 50 nM MeHg in absence or presence of 10 µM DA or DA alone from DIV1 until DIV5. On DIV5 glutamate (0-
600 µM) was added and exposed for another 2-4 days (DIV7-9). The viability was evaluated via MTT assay. The 
bars are represented as percentage of the glutamate-free basal control values.  The data are represented as 
mean ± SEM and were obtained in three independent trials, using triplicates per treatment condition.  
 
To study the protective effect of DA against MeHg toxicity, we did an experiment to investigate the 
role of DA receptors involved in this mechanism. A study by Coccini et al. (2011) (115) showed that 
exposure to MeHg leads to alterations in D1 and D2 receptors. We were interested in whether blocking 
the D2 receptor with 2 µM of the D2 receptor antagonist raclopride could prevent the protective effect 
of 10 µM DA.  
Using an MTT assay, we could not find any statistical significant difference between cells exposed to 
the MeHg-DA combination and the MeHg-DA-raclopride combination. The protective effect was not 
reduced by the additional exposure of the D2 receptor antagonist raclopride.  
Experiments were realized in two independent trials, using duplicates per treatment condition (data 
not shown).   
 
3.8 Effects of Combined MeHg-POPs Exposure on the Protective Effect of DA  
Due to the interesting effect of 10 µM DA, we wanted to investigate whether the same viability 
increasing effect could also be observed, if cells were exposed not only to MeHg but additionally to 
the 100x GM POPs mixture. 
 
Primary cortical neuronal cultures were exposed for 6-8 days (DIV1 to DIV6-8) to 10 µM DA in absence 
or presence of the 100x GM POPs mixture and MeHg at different concentrations (0-300 nM).  
 
  
42 
 
As no statistical difference at 0 nM MeHg between the two treatments was observable, values were 
normalized to the corresponding control value. In this experiment we also found the viability increasing 
effect of 10 µM DA, on cells exposed to MeHg and the POPs mixture at 100x GM concentrations. Figure 
16 shows that statistically significant cell viability increase was found at MeHg concentrations of 100, 
200 and 300 nM, with the biggest increase of 20% at 200 nM MeHg and POPs mixture. 
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FIG. 16. Concentration dependent viability of cortical neurons after exposure to different concentrations of 
MeHg and POPs mixture in absence or presence of 10 µM DA. Cells were exposed to the POPs mixture at 100x 
GM concentrations and MeHg concentrations in a range from 0-300 nM and 10 µM DA from DIV1 until DIV6-8. 
The viability was evaluated via MTT assay. The bars are represented as percentage of the MeHg-free basal control 
values. The data are represented as mean ± SEM and were obtained in three independent trials, using triplicates 
per treatment condition. Statistical significance is marked as ** (p < 0.01) and *** (p < 0.001). 
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4 DISCUSSION 
4.1 Effects of Combined Exposure of MeHg and Single Compound OCPs on Viability 
Our findings demonstrate that exposure of differentiating cortical neurons to MeHg in presence of the 
organochlorine pesticides dieldrin, HCB, β-HCH, δ-HCH, 4,4’-DDE, PCB-138 and PCB-153 at 100x GM 
concentrations do not increase the cytotoxic effect of MeHg. 
The literature on interactive toxicity of the seven used OCPs with MeHg is limited, only one study by 
Omara et al. (1997) (116) reports about no interactive toxicity if cells were exposed to MeHg and PCB 
mixtures concentrations in the same range as the used concentrations.  
 
Along our experiments we experienced difficulties with the 100 nM MeHg concentration, as depending 
on the cell culture, weaker cultures exhibited an increase in mortality at already 100 nM of MeHg, 
whereas less susceptible neurons of other primary cultures did not show any toxic effects at this 
concentration. It was interesting to observe that 100 nM of MeHg seemed to be a threshold value for 
MeHg toxicity. 
 
Four different assays were used to evaluate cell viability: MTT, resazurin and PI as quantitative assay, 
and immunostains as a qualitative method. We compared the three of them at the beginning of this 
project to find the optimal method. Although they showed the same pattern of cell viability in the same 
experiment, there were some quantitative differences between resazurin and MTT assay. MTT and PI 
assay exhibited the same quantitative results. Comparing resazurin with MTT assay, MTT results were 
more in accordance with the observations made via the phase-contrast microscope. Resazurin assays 
possibly would have needed adjusted reagent concentrations which would have cost time and 
material.  The PI assay is much more time-consuming if several plates have to be treated, as the small 
volume of reagent cannot be pipetted with the multi-step or repetition pipet. So we chose to do further 
viability evaluation by means of MTT assays only.  
 
The fourth technique, the immunostains, shows a qualitative image of the different conditions cells 
were exposed to. A less dense neuronal network was observed with increasing MeHg concentration, 
with no big difference regarding treatment condition, apart from cells exposed at 100 nM MeHg. Cells 
intoxicated with 100 nM MeHg in combination with POPs mixture seemed to be more susceptible. The 
decreased cellular morphology in the well exposed to MeHg and organochlorines could be explained 
by PCBs’ ability to depolymerize actin filaments that are interacting with microtubules (60), (61). At 100 
nM MeHg, the effect of the PCBs might have become observable in combination with the increased 
microtubule depolarizing activity of MeHg. The decreasing cell morphology due to MeHg exposure are 
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in accordance with a study by Miura et al. (1998) (59) that reports about the ability of MeHg to 
depolymerize microtubules (5*10-6 M MeHg/3 hours; Miura et al. (1998) (59)). 
The conflicting decrease in cell number seen at 100 nM MeHg, compared to no observable or just little 
toxic effect if evaluated by MTT, may be due to the fact that this culture might have been one of the 
more susceptible cultures. Furthermore, we have to take into account that despite constant cell 
density among the immunostains and MTT assay experiments, there was a difference in surface area 
of the culture wells.  This possibly influences neuronal distribution patterns and exposure physics. 
Lower concentrations of OCPs and MeHg might be necessary. 
 
4.2 Effects of Combined Exposure of MeHg and OCPs on Oxidative Stress 
As increased ROS production can render cells more susceptible and contribute to cell death (117), it 
seemed interesting to investigate the effect of MeHg and OCPs on ROS production in a chronic assay. 
But investigating ROS generation in cells exposed to MeHg over a longer period of time proved not to 
be easy, as MeHg concentrations higher than 50 nM would kill the cells and therefore, could not be 
compared to non-treated cells regarding their ROS levels. So we chose to first investigate ROS 
protective mechanisms at sub-toxic pollutant concentrations. Chronic exposure of cells to sub-toxic 50 
nM MeHg in combination with 100 nM HCB or 60 nM dieldrin did not seem to have any observable 
influence on ROS levels. Neither did single exposure of the compounds. Although studies by Francoa 
et al. (2009) (53) and Shinyashiki et al. (1996) (114) demonstrate inhibition in two important anti-oxidant 
enzymes, glutathione peroxidase (GPx) and superoxide dismutase, low dose MeHg concentrations did 
not show increased oxidative stress levels. This might be due to the fact that low dose MeHg 
concentrations do not cause enough inhibition of ROS neutralizing enzymes (25% GPx activity 
reduction at 1µM MeHg; Francoa et al. (2009) (53)) to influence oxidative stress levels.  
 
As we could not find any difference in oxidative stress levels at sub-toxic toxicant level, we investigated 
if MeHg, at concentrations that proved to be toxic in chronic exposure, and combined with various 
organochlorines, could induce oxidative stress. As we performed an acute assay, we used higher MeHg 
concentrations and the POPs mixture at 100x GM concentrations.  
We did not find any increase in ROS levels if cells were exposed to MeHg-POPs mixture combination, 
neither, if cells were exposed to MeHg or the mixture alone. Francoa et al. (2009) (53) demonstrated an 
increase in ROS levels at 1µM MeHg. The non-existing effect in our experiment might be due to the 
fact that cells in the study were exposed for 24 hours instead of 3 hours in our experiment. 
Furthermore, we were hypothesizing that the method might not have been sensitive enough. This, as 
well as the generally non-toxic concentration of PCBs in our experiment, could also be a valid 
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explanation for apparently no effects by PCBs, although there is evidence that PCBs principally have 
the ability to affect mitochondrial function and thus increase ROS (43). 
 
ROS and GSH are closely related, as GSH is important for neutralizing peroxides and thus reduces ROS 
levels. But GSH gets bound by MeHg due to its high affinity for thiol groups which in turn leads to 
increased ROS levels, as less free GSH is available (41). We were interested in how the combination of 
MeHg and POPs would affect GSH levels and if our previous ROS-results would be supported by the 
GSH assay. This is why we investigated the ability of MeHg and organochlorine pesticides of affecting 
GSH levels in primary culture cortical neurons. The combination of both of them did not alter GSH 
levels. 
A study by Gatti et al. (2004) (118) reports that 5µM MeHg depleted GSH levels of 15%. We might have 
seen no increase because we were using lower MeHg concentrations (maximum of 1µM). Studies 
investigating PCBs’ and 4,4’-DDE’s effect on GSH levels, are in agreement with our findings, as both 
didn’t show any influence on GSH levels (54), (55). 
 
Concluding on oxidative stress, our findings suggest that low MeHg and organochlorine concentrations 
do not affect cellular oxidative stress levels. In the experiments of literature findings, always higher 
(micromolar) MeHg concentrations were used. They are reported to increase statistically significant 
ROS production in a rat synaptosome (119) and cerebellar neurons (120), as well as GSH depletion (118). As 
the highest MeHg concentration we used was 1µM, we may conclude that at low MeHg (nanomolar) 
concentrations neither ROS generating mechanisms, nor ROS protective mechanisms or GSH levels are 
affected.  
 
4.3 Effects of Combined Exposure of MeHg and POPs mixture on ΔΨm 
Another cell parameter closely related with cell survival is the ΔΨm which as well is known to be 
affected by MeHg and organochlorines. Our experiment, investigating mitochondrial membrane 
depolarization, demonstrates that the 100x GM POPs mixture causes a loss of ΔΨm and that 
depolarization increases with increasing MeHg concentrations. But interestingly, in combination with 
the POPs mixture, increasing MeHg concentrations do not lead to an increased depolarization, but to 
reduced mitochondrial membrane depolarization, comparable to untreated cells. 
 
This result is supported by several literature findings. According to a study by Tofighi et al. (2011) (121), 
MeHg can lead to mitochondrial membrane depolarization in hippocampal neurons and mitochondrial 
dysfunction (122). The antagonistic effect of organochlorines and MeHg is in agreement with a study by 
Vettori et al. (2006) (123) that reports about antagonistic effects of PCB-153 and MeHg on lipid 
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peroxidation which is associated with mitochondrial membrane stability. A study supporting the ability 
of OCPs to depolarize the mitochondrial membrane is based upon the fact that mitochondrial calcium 
sequestration, which requires a membrane potential, is inhibited by PCBs (124), (125). There is also 
evidence that MeHg has the ability to induce release of inner mitochondrial calcium stores (45), (46). This 
occurs via the opening of the mitochondrial transition pore (MTP) and results in a membrane potential 
decrease (126). This again is supported by a study of Limke and Atchison (2002) (46) demonstrating the 
ability of MeHg to open the MTP.  
The opening of the MTP and consequent mitochondrial membrane depolarization occurs at 
intramitochondrial increased Ca2+ levels which will result in increased [Ca2+]i levels. It is known that β-
HCH and PCBs increase [Ca2+]i (48), (49), although it is not clear whether the increase in [Ca2+]i is a result 
of intramitochondrial calcium release or extracellular Ca2+ influx. In that case, β-HCH and PCBs might 
be responsible for the POPs mixture’s ability to depolarize the inner mitochondrial membrane. 
 
4.4 Effects of Combined MeHg-ACh and MeHg-DA Exposure on Cell Viability 
The fact that MeHg and organochlorines affect cell physiology, like ΔΨm, and their increased presence 
in people with PD (62), (64), (7) , led to the idea of studying how neurotransmitter involved in PD pathology 
would influence cell viability in combination with environmental pollutants. It has been suggested that 
PD is based upon a DA-ACh imbalance, which is the result of a loss of dopaminergic neurons (70), while 
cholinergic neurons remain unaffected (78). A similar situation occurs at prenatal exposure to MeHg: 
Developmental MeHg exposure is associated with a decreased number in dopaminergic neurons (104), 
while cholinergic neurons are not affected. As PD, associated with low dopamine levels, is linked to 
cortical atrophy too (66), we were interested in how DA and ACh would affect immature cortical neurons 
exposed to environmental pollutants. 
 
Our results demonstrate that cells exposed to MeHg in presence of 100 µM ACh, show an increase in 
cell mortality at the “threshold value” of 100 µM MeHg. 
  
Literature findings show that MeHg concentrations could increase ACh toxicity by increasing ACh 
concentrations which might be due to an inhibition of ACh esterase and an increase in ACh release (92), 
(93). The toxicity may be a result of a raise in [Ca2+]i  which occurs after stimulation of nicotinic ACh 
receptors (127). The increase in [Ca2+]i is in particular toxic for undifferentiated neurons because they 
can’t buffer big amounts of calcium yet (128).  We hypothesize that if MeHg inhibits ACh esterase and 
increases ACh release, the total ACh concentration and hence, the stimulation of nicotinic ACh 
receptors is increased. This results in increased, toxic [Ca2+]i levels. As cells at 100 µM MeHg, the 
“threshold value”, are in general more vulnerable, increased ACh concentration may lead to increased 
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cell death, compared to cells exposed to MeHg only. The fact that we do not see any increased cell 
mortality in MeHg concentrations higher than 100 nM, might be due to the toxicity of MeHg that seems 
to exceed ACh toxicity. The exact mode of action is not known, but may involve ACh receptors, as they 
can influence cell physiology with a broad variety of mechanisms, as explained in section 1.8. 
   
The interactive toxicity of MeHg and ACh should also be taken in account as additional risk of smoking 
mothers who are exposed to mercury not only by fish consumption, but by cigarettes (129) too. 
Increased nicotine levels are found in foetuses of smoking mothers (130) that may also lead to increased 
ACh release (131). This effect would even be worsened in combination with the mercury of the cigarettes 
and could lead to increased cell mortality. 
 
Our experiments investigating DA show that cells exposed to toxic MeHg concentrations exhibit less 
mortality if co-exposed to 10 µM DA. We found the same effect if MeHg was combined with the POPs 
mixture.  
 
On the look for possible mechanisms involved in this protective effect of 10 µM DA, we started by 
investigating glutamate-induced excitotoxicity, which can be elicited by MeHg exposure. This 
hypothesis was based upon a study by Vaarman et al. (2013) (132), who showed a protective effect of 
DA against glutamate-induced excitotoxicity. Although effective concentrations against glutamate-
induced excitotoxicity were smaller than 10 µM DA, we wanted to study if 10 µM DA, which proved to 
be protective against MeHg in our case, would also protect against glutamate-induced excitotoxicity 
in combination with MeHg. Furthermore, we wanted to investigate the possible ability of a sub-toxic 
MeHg concentration to promote excitoxicity. But our results demonstrated that sub-toxic MeHg 
concentrations do not induce excitotoxicity, nor do 10 µM DA protect against glutamate-induced 
excitotoxicity. So we may conclude that 10 µM DA do not protect against glutamate-induced 
excitotoxicity by MeHg. Furthermore, the findings that MeHg and the POPs mixture do not induce 
excitotoxicity are in agreement with our findings that MeHg and POPs mixture do not induce ROS 
production: Excitotoxicity is known to increase ROS levels (51). Therefore, no increase in excitotoxicity 
by MeHg and POPs mixture is in consonance with no rise in ROS production due to MeHg and POPs 
mixture. 
 
Although we could not demonstrate any increase in excitotoxicity, Petroni et al. (2013) (133) provide 
evidence for an increase in toxicity in SH-SY5Y neuroblastoma cells if they were exposed to 50 nM 
MeHg in combination with 1 mM glutamate compared to glutamate only. But these cells seem to be 
generally more susceptible to MeHg: In this study 50 nM MeHg alone cause already a viability decrease 
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of 30%. Furthermore, 600 µM glutamate were highest glutamate concentration, compared to 1 mM in 
the previously mentioned study. 
 
Therefore, our search for a possible explanation for the protective effect of DA continued and we 
focused on the D2 receptor. Literature findings suggest that the D2 receptor is responsible for the 
protective effect of DA (132), (134). Despite this fact, we did not find any D2 receptor-mediated protective 
effect, as we used the D2 receptor antagonist raclopride at 2 µM to investigate a possible D2 receptor 
effect. Although the IC50 of raclopride is 32 nM, we used a higher concentration to be sure that it would 
block efficiently in presence of 10 µM DA. But no effect was observed. 
 
Concluding on the mechanisms of action of DA, we can say that the protective effect of 10 µM DA 
against MeHg-induced toxicity was not affected by additional OCP exposure. Furthermore, this 
protective effect is not due to effects involving mechanisms against excitotoxicity or D2 receptor-
mediated actions. Regarding the protective effect of DA, it should be further investigated whether 
other DA receptors or transporters are involved in this mechanism. 
 
In conclusion, the results of our experiments, investigating the impact of DA and ACh in cortical 
neurons exposed to MeHg and organochlorines, highlight the link between prenatal MeHg exposure, 
DA-ACh imbalance and cortical atrophy in PD: Decreased number of dopaminergic neurons by prenatal 
MeHg exposure (104) leads in total to a loss of projections to the cortex resulting in a lack of DA there. 
This renders cortical neurons more susceptible to the toxic effects of MeHg, as the protective effect of 
DA is lacking. In turn, the presence of ACh, in combination with MeHg and organochlorines, might even 
contribute to the loss of cortical neurons, if the number of dopaminergic neurons, hence the dopamine 
concentration, is reduced. The reduced number of dopaminergic neurons, in turn, might increase the 
risk of developing PD and of cortical atrophy induced by low-dose MeHg.  
 
4.5 Conclusions 
Generally, our results are in agreement with relevant literature. Our findings demonstrate that at 
environmental concentrations, MeHg seems to be a greater risk for a developing nervous system than 
organochlorines. The mitochondrial membrane depolarizing effect of the OCPs and MeHg alone, which 
is counteracted by the combination of both, provides evidence for possible interactive effects of MeHg 
and organochlorine pollutants without affecting cell viability. Additionally, the cell mortality-increasing 
effect of combined MeHg and ACh exposure should be taken into account in further investigations on 
the topic of environmental pollutant-induced PD. This finding addresses also more awareness to the 
harmful effects of smoking while pregnancy. Foetuses of smoking mothers are exposed to both 
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compounds and thus are more vulnerable to neuronal degeneration. The beneficial effect of DA 
against MeHg neurotoxicity and in PD treatment suggests that the harmful effect of low-dose MeHg 
concentrations might be increased in PD patients as protecting DA levels are reduced.  
Concluding, our experiments and literature provide evidence that MeHg alone or in combination with 
organochlorine pollutants or ACh can have harmful effects on human health and therefore should be 
further investigated. Interactions of MeHg with DA could provide useful information for the 
development of nutritional supplements for pregnant women in regions with a high mercury burden 
and could be a hint for further PD and PD progenitor cell transplant research. 
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ABSTRACT  
Methylmercury’s (MeHg) devastating health effects were demonstrated in the Minamata disease 
outbreak in Japan when people were exposed over decades to low MeHg concentrations, which 
resulted in severe brain damage and long-term effects affecting the central nervous system.  But MeHg 
is not the only perfidious compound causing harm to the human brain at chronic low-dose exposure. 
Organochlorine compounds, used as pesticides or in industry, and present in daily life have a big 
potential to cause neurological damage too. Exposure to both groups of toxicants, MeHg and 
organochlorine compounds, are linked to neurodegenerative diseases, including Parkinson’s disease. 
We wanted to investigate cytotoxic effects of MeHg in combination with various organochlorine 
compounds and neurotransmitters involved in Parkinson’s disease pathology: acetylcholine and 
dopamine.  
We did not find any interactive cytotoxic effect between MeHg and organochlorines. Furthermore, 
there was also no evidence for interactive effects of MeHg and organochlorines involved in oxidative 
stress. But measurements of the mitochondrial membrane potential showed that a mixture of various 
organochlorine compounds and MeHg, depolarizes mitochondrial membrane, but in combination 
counteract mitochondrial membrane depolarization. By researching MeHg in combination with 
Acetylcholine we could show that 100 µM acetylcholine can increase toxicity at MeHg concentrations 
of little toxicity. Furthermore, dopamine seems to have a protective effect against MeHg toxicity, 
which is not diminished by additional exposure to a mixture of numerous organochlorines. Moreover, 
we found that neither D2-receptor mediated actions, nor protection against glutamate-induced 
excitotoxicty is the mode of action in dopamine’s protective actions. 
We hypothesize that the mitochondrial membrane depolarization occurs due to opening of the 
mitochondrial membrane transition pore induced by intramitochondrial rise in Ca2+ which can be 
induced, according to literature findings, by MeHg and various organochlorines. The interactive 
harmful effect of acetylcholine and interactive protective effect of dopamine in combination with 
environmental pollutants provide useful information for neuronal progenitor cell transplantations, a 
potential cure for neurodegenerative diseases, in people with high environmental pollutant burden. 
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ABSTRACT (DEUTSCH) 
Methylquecksilbers (MeHg) verheerende Auswirkungen auf die Gesundheit wurden bei Ausbruch der 
Minamata-Krankheit in Japan deutlich, als die lokale Bevölkerung über Jahrzehnte hinweg niedrigen 
Dosen von MeHg ausgesetzt war, was zu schweren Hirnschäden und Schädigungen des Zentralen 
Nervensystems führte. Aber MeHg ist nicht das einzige Umweltgift, das dem menschlichen Gehirn, 
sogar in sehr geringen Dosen, Schaden zufügen kann. Organochlorine, die als Pestizide oder in der 
Industrie Verwendung finden, und denen man im täglichen Leben ausgesetzt ist, haben auch großes 
Potential neurologische Erkrankungen hervorzurufen. Belastung mit Umweltgiften, wie MeHg und 
Organochlorine, sind mit neurodegenerativen Erkrankungen assoziiert, unter anderem Parkinson. Wir 
wollten mögliche cytotoxische Effekte von MeHg in Kombination mit diversen Organochlorinen und 
Neurotransmittern, die in der Pathologie von Parkinson eine Rolles spielen, nämlich Acetylcholin und 
Dopamin, erforschen.  
Wir konnten keine interaktiven cytotoxischen Effekte zwischen MeHg und Organochlorinen finden, 
ebenso wenig wie interaktive Effekte zwischen MeHg und Organochlorinen in Bezug auf oxidativen 
Stress. Allerdings konnten wir zeigen, dass MeHg und ein Mix aus Organochlorinen die innnere 
Mitochondrienmembran teilweise depolarisieren kann. Aber in Kombination von MeHg und 
Organochlorin-Mix, kommt es zu einem der Depolarisation entgegengesetzten Effekt.  Außerdem 
wurde gezeigt, dass 100 µM Ach -alleine ein sub-toxische Konzentration- in Kombination mit 100 nM 
MeHg zu vermehrtem Zellensterben führt. Außerdem haben unsere Experimente gezeigt, dass 
Dopamin  schützend gegen die toxischen Effekte von MeHg wirkt. Dieser Effekt wird nicht von dem 
Organochlorin-Mix beeinflusst. Wir fanden heraus, dass der schützende Effekt gegen MeHg nicht auf 
einem Schutz vor Exzitotoxizität oder Mechanismen auf Grund einer Dopamin D2-Rezeptor-Aktivierung 
beruht. 
Wir denken, dass die Depolarisation der mitochondriellen Membran auf der Öffnung der 
„mitochondrial transition pore“ durch Zunahme an intramitochondriellen Kalziumkonzentration 
basiert. Die Zunahme intramitochondrieller Kalziumkonzentrationen kann, laut Literatur, durch MeHg 
oder Organochlorine hervorgerufen werden. Der interaktive schädliche Effekt von Acetylcholin und 
der interaktive schützende Effekt von Dopamin in Kombination mit Umweltgiften liefern nützliche 
Informationen für die Erforschung eine mögliche Therapie für Parkinson-Patienten, die mit hohen 
körperlichen Konzentrationen an Umweltgiften belastet sind. 
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